DGAP-News: Special Committee of Helix BioPharma Corp. Provides Update to Shareholders
Helix BioPharma Corp. / Key word(s): Miscellaneous
26.01.2012 02:08
—————————————————————————
AURORA, ON — (Marketwire) — 01/25/12 — The Special Committee of
the Board of Directors of Helix BioPharma Corp. (TSX: HBP) (NYSE
Amex: HBP) (FRANKFURT: HBP) (the –Company– or –Helix–) announces that
Ernst&Young LLP (–Ernst&Young–) has delivered its Interim Report.
As announced on December 6, 2011, the Special Committee engaged Erns
